Clinical Nuclear Medicine · 1996 · 15 citations · 11 references
MedicineNuclear MedicineEndocrine Nuclear MedicineOncologic Nuclear MedicineTherapeutic Nuclear MedicineParathyroid Adenoma LocalizationParathyroid CancerParathyroid DisordersParathyroid ImagingParathyroid NeoplasmsThyroid CancerParathyroid Adenoma ManagementParathyroid PathologyParathyroid Tumor DiagnosisParathyroid Tumor ImagingRadiopharmaceuticals For Parathyroid ImagingSestamibi Parathyroid ImagingTechnetium-99m Pertechnetate ImagingTechnetium-99m Pertechnetate Scanning
The uptake of Tc-99m tetrofosmin (TF) is reported in a case of parathyroid adenoma. A 65-year-old woman was studied on different days with TF, Tc-99m sestamibi (MIBI) and Tl-201 chloride (Tl). TF and MIBI injections were preceded by oral administration of potassium perchlorate. Clear identification of the adenoma was observed in all scans. No further information was obtained using a subtraction technique with Tc-99m pertechnetate. Regarding the thyroid/parathyroid ratio, different kinetics between TF and MIBI appear to be demonstrated. In particular, thyroid washout was observed with MIBI but not with TF.
11
Raymond Taillefer, Y Boucher, Claude Potvin et al. · PubMed · 1992 · 543 citations
New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan.
G. Ferlin, N. Borsato, M. Camerani et al. · PubMed · 1983 · 171 citations